Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 280

1.

Host-derived Spi6 provides granzyme B-independent protection of intestinal epithelial cells in murine GVHD.

Mohammadpour H, Du W, O'Neil R, Khalili S, Qiu J, Repasky EA, McCarthy PL, Cao X.

Biol Blood Marrow Transplant. 2018 Jul 10. pii: S1083-8791(18)30388-4. doi: 10.1016/j.bbmt.2018.07.003. [Epub ahead of print]

PMID:
30006303
2.

Next-Generation Drugs Targeting the Cereblon Ubiquitin Ligase.

Holstein SA, Hillengass J, McCarthy PL.

J Clin Oncol. 2018 Jul 10;36(20):2101-2104. doi: 10.1200/JCO.2018.77.9637. Epub 2018 May 1. No abstract available.

PMID:
29715055
3.

Exome chip analyses identify genes affecting mortality after HLA-matched unrelated-donor blood and marrow transplantation.

Zhu Q, Yan L, Liu Q, Zhang C, Wei L, Hu Q, Preus L, Clay-Gilmour AI, Onel K, Stram DO, Pooler L, Sheng X, Haiman CA, Zhu X, Spellman SR, Pasquini M, McCarthy PL, Liu S, Hahn T, Sucheston-Campbell LE.

Blood. 2018 May 31;131(22):2490-2499. doi: 10.1182/blood-2017-11-817973. Epub 2018 Apr 2.

PMID:
29610366
4.

The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.

Andermann TM, Peled JU, Ho C, Reddy P, Riches M, Storb R, Teshima T, van den Brink MRM, Alousi A, Balderman S, Chiusolo P, Clark WB, Holler E, Howard A, Kean LS, Koh AY, McCarthy PL, McCarty JM, Mohty M, Nakamura R, Rezvani K, Segal BH, Shaw BE, Shpall EJ, Sung AD, Weber D, Whangbo J, Wingard JR, Wood WA, Perales MA, Jenq RR, Bhatt AS; Blood and Marrow Transplant Clinical Trials Network.

Biol Blood Marrow Transplant. 2018 Jul;24(7):1322-1340. doi: 10.1016/j.bbmt.2018.02.009. Epub 2018 Feb 19. No abstract available.

PMID:
29471034
5.

Blockade of Host β2-Adrenergic Receptor Enhances Graft-versus-Tumor Effect through Modulating APCs.

Mohammadpour H, O'Neil R, Qiu J, McCarthy PL, Repasky EA, Cao X.

J Immunol. 2018 Apr 1;200(7):2479-2488. doi: 10.4049/jimmunol.1701752. Epub 2018 Feb 14.

PMID:
29445008
6.

Serine protease inhibitor 6 protects alloreactive T cells from Granzyme B-mediated mitochondrial damage without affecting graft-versus-tumor effect.

Du W, Mohammadpour H, O'Neill RE, Kumar S, Chen C, Qiu M, Mei L, Qiu J, McCarthy PL, Lee KP, Cao X.

Oncoimmunology. 2017 Nov 16;7(3):e1397247. doi: 10.1080/2162402X.2017.1397247. eCollection 2018.

PMID:
29399396
7.

BPX-501 T cells interfere with minimal residual disease evaluation of B-cell acute lymphoblastic leukemia.

Amro Elshoury, Wallace PK, Borowitz MJ, Kader A, Choi C, Ho C, Balderman S, Ross M, Hahn T, O'Neill V, McCarthy PL, Chen GL.

Bone Marrow Transplant. 2018 May;53(5):651-653. doi: 10.1038/s41409-017-0036-x. Epub 2018 Jan 17. No abstract available.

PMID:
29343836
8.

Genetic association with B-cell acute lymphoblastic leukemia in allogeneic transplant patients differs by age and sex.

Clay-Gilmour AI, Hahn T, Preus LM, Onel K, Skol A, Hungate E, Zhu Q, Haiman CA, Stram DO, Pooler L, Sheng X, Yan L, Liu Q, Hu Q, Liu S, Battaglia S, Zhu X, Block AW, Sait SNJ, Karaesmen E, Rizvi A, Weisdorf DJ, Ambrosone CB, Tritchler D, Ellinghaus E, Ellinghaus D, Stanulla M, Clavel J, Orsi L, Spellman S, Pasquini MC, McCarthy PL, Sucheston-Campbell LE.

Blood Adv. 2017 Sep 8;1(20):1717-1728. doi: 10.1182/bloodadvances.2017006023. eCollection 2017 Sep 12.

9.

Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT.

Ho CM, McCarthy PL, Wallace PK, Zhang Y, Fora A, Mellors P, Tario JD, McCarthy BLS, Chen GL, Holstein SA, Balderman SR, Cao X, Paiva B, Hahn T.

Blood Adv. 2017 Jun 20;1(15):1056-1066. doi: 10.1182/bloodadvances.2017005447. eCollection 2017 Jun 27.

10.

BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee.

Holstein SA, Avet-Loiseau H, Hahn T, Ho CM, Lohr JG, Munshi NC, Paiva B, Pasquini MC, Tario JD Jr, Usmani SZ, Wallace PK, Weisel K, McCarthy PL.

Biol Blood Marrow Transplant. 2018 Apr;24(4):641-648. doi: 10.1016/j.bbmt.2017.12.774. Epub 2017 Dec 11. Review.

PMID:
29242112
11.

Lenalidomide in combination or alone as maintenance therapy following autologous stem cell transplant in patients with multiple myeloma: a review of options for and against.

Richardson PG, Holstein SA, Schlossman RL, Anderson KC, Attal M, McCarthy PL.

Expert Opin Pharmacother. 2017 Dec;18(18):1975-1985. doi: 10.1080/14656566.2017.1409207. Epub 2017 Dec 1. Review.

PMID:
29172855
12.

Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease.

Chen GL, Carpenter PA, Broady R, Gregory TK, Johnston LJ, Storer BE, Beumer JH, Qiu J, Cerda K, Le R, Otani JM, Liu H, Ross MA, Arai S, Flowers MED, McCarthy PL, Miklos DB.

Biol Blood Marrow Transplant. 2018 Feb;24(2):373-380. doi: 10.1016/j.bbmt.2017.10.021. Epub 2017 Oct 16.

PMID:
29051021
13.

T Cell-Derived CD70 Delivers an Immune Checkpoint Function in Inflammatory T Cell Responses.

O'Neill RE, Du W, Mohammadpour H, Alqassim E, Qiu J, Chen G, McCarthy PL, Lee KP, Cao X.

J Immunol. 2017 Nov 15;199(10):3700-3710. doi: 10.4049/jimmunol.1700380. Epub 2017 Oct 18.

PMID:
29046346
14.

Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial.

Holstein SA, Jung SH, Richardson PG, Hofmeister CC, Hurd DD, Hassoun H, Giralt S, Stadtmauer EA, Weisdorf DJ, Vij R, Moreb JS, Callander NS, van Besien K, Gentile TG, Isola L, Maziarz RT, Bashey A, Landau H, Martin T, Qazilbash MH, Rodriguez C, McClune B, Schlossman RL, Smith SE, Hars V, Owzar K, Jiang C, Boyd M, Schultz C, Wilson M, Hari P, Pasquini MC, Horowitz MM, Shea TC, Devine SM, Linker C, Anderson KC, McCarthy PL.

Lancet Haematol. 2017 Sep;4(9):e431-e442. doi: 10.1016/S2352-3026(17)30140-0. Epub 2017 Aug 17.

PMID:
28826616
15.

Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant.

Karaesmen E, Rizvi AA, Preus LM, McCarthy PL, Pasquini MC, Onel K, Zhu X, Spellman S, Haiman CA, Stram DO, Pooler L, Sheng X, Zhu Q, Yan L, Liu Q, Hu Q, Webb A, Brock G, Clay-Gilmour AI, Battaglia S, Tritchler D, Liu S, Hahn T, Sucheston-Campbell LE.

Blood. 2017 Sep 28;130(13):1585-1596. doi: 10.1182/blood-2017-05-784637. Epub 2017 Aug 15.

16.

Ascertainment of Unmet Needs and Participation in Health Maintenance and Screening of Adult Hematopoietic Cell Transplantation Survivors Followed in a Formal Survivorship Program.

Hahn T, Paplham P, Austin-Ketch T, Zhang Y, Grimmer J, Burns M, Balderman S, Ross M, McCarthy PL.

Biol Blood Marrow Transplant. 2017 Nov;23(11):1968-1973. doi: 10.1016/j.bbmt.2017.07.024. Epub 2017 Aug 4.

PMID:
28782599
17.

Observational Assessment in the Febrile Infant.

McCarthy PL.

Pediatrics. 2017 Jul;140(1). pii: e20171100. doi: 10.1542/peds.2017-1100. Epub 2017 Jun 6. No abstract available.

18.

Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis.

McCarthy PL, Holstein SA, Petrucci MT, Richardson PG, Hulin C, Tosi P, Bringhen S, Musto P, Anderson KC, Caillot D, Gay F, Moreau P, Marit G, Jung SH, Yu Z, Winograd B, Knight RD, Palumbo A, Attal M.

J Clin Oncol. 2017 Oct 10;35(29):3279-3289. doi: 10.1200/JCO.2017.72.6679. Epub 2017 Jul 25.

PMID:
28742454
19.

Host-Derived CD70 Suppresses Murine Graft-versus-Host Disease by Limiting Donor T Cell Expansion and Effector Function.

Leigh ND, O'Neill RE, Du W, Chen C, Qiu J, Ashwell JD, McCarthy PL, Chen GL, Cao X.

J Immunol. 2017 Jul 1;199(1):336-347. doi: 10.4049/jimmunol.1502181. Epub 2017 May 26.

20.

Second primary malignancies in multiple myeloma: an overview and IMWG consensus.

Musto P, Anderson KC, Attal M, Richardson PG, Badros A, Hou J, Comenzo R, Du J, Durie BGM, San Miguel J, Einsele H, Chen WM, Garderet L, Pietrantuono G, Hillengass J, Kyle RA, Moreau P, Lahuerta JJ, Landgren O, Ludwig H, Larocca A, Mahindra A, Cavo M, Mazumder A, McCarthy PL, Nouel A, Rajkumar SV, Reiman A, Riva E, Sezer O, Terpos E, Turesson I, Usmani S, Weiss BM, Palumbo A; International Myeloma Working Group.

Ann Oncol. 2018 Apr 1;29(4):1074. doi: 10.1093/annonc/mdx160. No abstract available.

PMID:
28541409
21.

Immunomodulatory Drugs in Multiple Myeloma: Mechanisms of Action and Clinical Experience.

Holstein SA, McCarthy PL.

Drugs. 2017 Apr;77(5):505-520. doi: 10.1007/s40265-017-0689-1. Review.

22.

Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients.

Kishi T, Rider LG, Pak K, Barillas-Arias L, Henrickson M, McCarthy PL, Shaham B, Weiss PF, Horkayne-Szakaly I, Targoff IN, Miller FW, Mammen AL; Childhood Myositis Heterogeneity Study Group.

Arthritis Care Res (Hoboken). 2017 Jul;69(7):1088-1094. doi: 10.1002/acr.23113.

23.

Role of stem cell transplant and maintenance therapy in plasma cell disorders.

McCarthy PL, Holstein SA.

Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):504-511. Review.

PMID:
27913522
24.

Second primary malignancies in multiple myeloma: an overview and IMWG consensus.

Musto P, Anderson KC, Attal M, Richardson PG, Badros A, Hou J, Comenzo R, Du J, Durie BGM, San Miguel J, Einsele H, Chen WM, Garderet L, Pietrantuono G, Hillengass J, Kyle RA, Moreau P, Lahuerta JJ, Landgren O, Ludwig H, Larocca A, Mahindra A, Cavo M, Mazumder A, McCarthy PL, Nouel A, Rajkumar SV, Reiman A, Riva E, Sezer O, Terpos E, Turesson I, Usmani S, Weiss BM, Palumbo A; International Myeloma Working Group.

Ann Oncol. 2017 Feb 1;28(2):228-245. doi: 10.1093/annonc/mdw606. Review. Erratum in: Ann Oncol. 2017 May 24;:.

25.

Granzyme B Contributes to the Optimal Graft-Versus-Tumor Effect Mediated by Conventional CD4+ T Cells.

Du W, Leigh ND, Bian G, Alqassim E, O'Neill RE, Mei L, Qiu J, Liu H, McCarthy PL, Cao X.

J Immunol Res Ther. 2016;1(1):22-28. Epub 2016 Apr 30.

26.

Acute Stroke in a Girl With an Absent Radial Pulse.

Ghoshal S, Bronen RA, McCarthy PL, Pels SG, Beslow LA.

Pediatr Neurol. 2016 Sep;62:77-8. doi: 10.1016/j.pediatrneurol.2016.06.002. Epub 2016 Jun 11. No abstract available.

PMID:
27436537
27.

Improved survival with salvage autologous stem-cell transplantation in myeloma.

Holstein SA, McCarthy PL.

Lancet Haematol. 2016 Jul;3(7):e306-7. doi: 10.1016/S2352-3026(16)30058-8. No abstract available.

PMID:
27374462
28.

Quantifying MHC dextramer-induced NFAT activation in antigen-specific T cells as a functional response parameter.

Maguire O, Chen GL, Hahn TE, Brix L, McCarthy PL, Wallace PK, Minderman H.

Methods. 2017 Jan 1;112:75-83. doi: 10.1016/j.ymeth.2016.06.014. Epub 2016 Jun 17.

29.

Financial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot study.

Denzen EM, Thao V, Hahn T, Lee SJ, McCarthy PL, Rizzo JD, Ammi M, Drexler R, Flesch S, James H, Omondi N, Murphy E, Pederson K, Majhail NS.

Bone Marrow Transplant. 2016 Sep;51(9):1233-40. doi: 10.1038/bmt.2016.103. Epub 2016 Apr 18.

30.

Discontinuation of Systematic Surveillance and Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) and Its Impact on the Incidence of VRE faecium Bacteremia in Patients with Hematologic Malignancies.

Almyroudis NG, Osawa R, Samonis G, Wetzler M, Wang ES, McCarthy PL, Segal BH.

Infect Control Hosp Epidemiol. 2016 Apr;37(4):398-403. doi: 10.1017/ice.2015.310. Epub 2016 Jan 11.

PMID:
26750087
31.

Continued role for ASCT in multiple myeloma.

McCarthy PL, Holstein SA.

Lancet Oncol. 2015 Dec;16(16):1571-3. doi: 10.1016/S1470-2045(15)00457-X. Epub 2015 Nov 17. No abstract available.

PMID:
26596669
32.

Housing Temperature-Induced Stress Is Suppressing Murine Graft-versus-Host Disease through β2-Adrenergic Receptor Signaling.

Leigh ND, Kokolus KM, O'Neill RE, Du W, Eng JW, Qiu J, Chen GL, McCarthy PL, Farrar JD, Cao X, Repasky EA.

J Immunol. 2015 Nov 15;195(10):5045-54. doi: 10.4049/jimmunol.1500700. Epub 2015 Oct 12.

33.

Granzyme B-Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease.

Du W, Leigh ND, Bian G, O'Neill RE, Mei L, Qiu J, Chen GL, Hahn T, Liu H, McCarthy PL, Cao X.

J Immunol. 2015 Nov 1;195(9):4514-23. doi: 10.4049/jimmunol.1500668. Epub 2015 Sep 21.

34.

Establishment of Definitions and Review Process for Consistent Adjudication of Cause-specific Mortality after Allogeneic Unrelated-donor Hematopoietic Cell Transplantation.

Hahn T, Sucheston-Campbell LE, Preus L, Zhu X, Hansen JA, Martin PJ, Yan L, Liu S, Spellman S, Tritchler D, Clay A, Onel K, Pasquini M, McCarthy PL.

Biol Blood Marrow Transplant. 2015 Sep;21(9):1679-1686. doi: 10.1016/j.bbmt.2015.05.019. Epub 2015 May 29.

35.

Consolidation and maintenance therapy for multiple myeloma after autologous transplantation: where do we stand?

Mohty M, Richardson PG, McCarthy PL, Attal M.

Bone Marrow Transplant. 2015 Aug;50(8):1024-9. doi: 10.1038/bmt.2015.83. Epub 2015 Apr 20. Review.

PMID:
25893452
36.

Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study.

Sorror ML, Logan BR, Zhu X, Rizzo JD, Cooke KR, McCarthy PL, Ho VT, Horowitz MM, Pasquini MC.

Biol Blood Marrow Transplant. 2015 Aug;21(8):1479-87. doi: 10.1016/j.bbmt.2015.04.004. Epub 2015 Apr 7.

37.

The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia.

Holter-Chakrabarty JL, Pierson N, Zhang MJ, Zhu X, Akpek G, Aljurf MD, Artz AS, Baron F, Bredeson CN, Dvorak CC, Epstein RB, Lazarus HM, Olsson RF, Selby GB, Williams KM, Cooke KR, Pasquini MC, McCarthy PL.

Biol Blood Marrow Transplant. 2015 Jul;21(7):1251-7. doi: 10.1016/j.bbmt.2015.03.017. Epub 2015 Mar 31.

38.

Identification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime?

Sucheston-Campbell LE, Clay A, McCarthy PL, Zhu Q, Preus L, Pasquini M, Onel K, Hahn T.

Curr Hematol Malig Rep. 2015 Mar;10(1):45-58. doi: 10.1007/s11899-014-0246-x. Review.

39.

Synchronous presentation of monoclonal gammopathy and Fabry nephropathy; diagnostic renal biopsy obviates initiation of myeloma therapy.

Pokuri VK, Xu B, Neppalli V, Czyzyk J, Berenji F, Holstein SA, McCarthy PL.

Ann Hematol. 2015 Jun;94(6):1067-8. doi: 10.1007/s00277-015-2307-1. Epub 2015 Feb 10. No abstract available.

PMID:
25666077
40.

Management of relapsed multiple myeloma after autologous stem cell transplant.

Holstein SA, Richardson PG, Laubach JP, McCarthy PL.

Biol Blood Marrow Transplant. 2015 May;21(5):793-8. doi: 10.1016/j.bbmt.2014.12.026. Epub 2015 Jan 31. Review.

41.

Multiple myeloma.

Holstein SA, Liu H, McCarthy PL.

Hematol Oncol Clin North Am. 2014 Dec;28(6):1113-29. doi: 10.1016/j.hoc.2014.08.010. Epub 2014 Sep 30. Review.

PMID:
25459182
42.

Complementary and integrative methods in fibromyalgia.

Ali A, McCarthy PL.

Pediatr Rev. 2014 Dec;35(12):510-8. doi: 10.1542/pir.35-12-510. Review. No abstract available.

43.

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.

Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, Urbano-Ispizua A, Cutler CS, Bacigalupo AA, Battiwalla M, Flowers ME, Juckett MB, Lee SJ, Loren AW, Klumpp TR, Prockup SE, Ringdén OT, Savani BN, Socié G, Schultz KR, Spitzer T, Teshima T, Bredeson CN, Jacobsohn DA, Hayashi RJ, Drobyski WR, Frangoul HA, Akpek G, Ho VT, Lewis VA, Gale RP, Koreth J, Chao NJ, Aljurf MD, Cooper BW, Laughlin MJ, Hsu JW, Hematti P, Verdonck LF, Solh MM, Norkin M, Reddy V, Martino R, Gadalla S, Goldberg JD, McCarthy PL, Pérez-Simón JA, Khera N, Lewis ID, Atsuta Y, Olsson RF, Saber W, Waller EK, Blaise D, Pidala JA, Martin PJ, Satwani P, Bornhäuser M, Inamoto Y, Weisdorf DJ, Horowitz MM, Pavletic SZ; Graft-vs-Host Disease Working Committee of the CIBMTR.

Biol Blood Marrow Transplant. 2015 Feb;21(2):266-74. doi: 10.1016/j.bbmt.2014.10.021. Epub 2014 Oct 30.

44.

Comparison of non-myeloablative conditioning regimens for lymphoproliferative disorders.

Hong S, Le-Rademacher J, Artz A, McCarthy PL, Logan BR, Pasquini MC.

Bone Marrow Transplant. 2015 Mar;50(3):367-74. doi: 10.1038/bmt.2014.269. Epub 2014 Dec 1.

45.

Dextramer reagents are effective tools for quantifying CMV antigen-specific T cells from peripheral blood samples.

Tario JD Jr, Chen GL, Hahn TE, Pan D, Furlage RL, Zhang Y, Brix L, Halgreen C, Jacobsen K, McCarthy PL, Wallace PK.

Cytometry B Clin Cytom. 2015 Jan;88(1):6-20. doi: 10.1002/cyto.b.21196. Epub 2014 Oct 23.

46.

Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy.

Eapen M, Logan BR, Appelbaum FR, Antin JH, Anasetti C, Couriel DR, Chen J, Maziarz RT, McCarthy PL, Nakamura R, Ratanatharathorn V, Vij R, Champlin RE.

Biol Blood Marrow Transplant. 2015 Jan;21(1):55-9. doi: 10.1016/j.bbmt.2014.09.006. Epub 2014 Sep 22.

47.

Maintenance therapy for multiple myeloma.

McCarthy PL, Palumbo A.

Hematol Oncol Clin North Am. 2014 Oct;28(5):839-59. doi: 10.1016/j.hoc.2014.06.006. Epub 2014 Jul 22. Review.

PMID:
25212886
48.

Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1.

Fleischhauer K, Fernandez-Viña MA, Wang T, Haagenson M, Battiwalla M, Baxter-Lowe LA, Ciceri F, Dehn J, Gajewski J, Hale GA, Heemskerk MB, Marino SR, McCarthy PL, Miklos D, Oudshoorn M, Pollack MS, Reddy V, Senitzer D, Shaw BE, Waller EK, Lee SJ, Spellman SR.

Bone Marrow Transplant. 2014 Sep;49(9):1176-83. doi: 10.1038/bmt.2014.122. Epub 2014 Jun 23.

49.

Second transplant as a standard for multiple myeloma.

McCarthy PL.

Lancet Oncol. 2014 Jul;15(8):786-8. doi: 10.1016/S1470-2045(14)70279-7. Epub 2014 Jun 16. No abstract available.

PMID:
24948587
50.

Fludarabine and cyclophosphamide provides a nonmyeloablative alternative conditioning regimen with low transplant-related mortality and control of high risk disease.

Paplham P, Hahn T, Dubel K, Lipka P, McCarthy PL.

Leuk Res Rep. 2014 Apr 18;3(1):28-31. doi: 10.1016/j.lrr.2014.03.001. eCollection 2014.

Supplemental Content

Loading ...
Support Center